Kevin T. Larkin

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Ventritex, Inc. designs, develops, manufactures and markets implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation.

Coapt Systems, Inc. designs, develops, manufactures and markets bio absorbable implants for surgeons to use in plastic surgery to fixate soft tissue to other soft tissue and bone. The company was founded in 2000 and is headquartered in Palo Alto, CA.

Encapsule Medical Devices LLC is a privately-held medical device company focused on the development and commercialization of minimally invasive breast biopsy and tissue removal technologies. The company is based in Redwood City, California. The Encapsule Medical team redefines breast care and ultimately changes the way physicians diagnose and treat breast cancer and benign breast disease. Encapsule Medical markets three breast care devices in the U.S. for the biopsy and removal of breast lesions.

Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. It specializes in robotic-assisted surgery and medical devices. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Pleasanton, CA.

TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA.

CardioVasc, Inc. manufactured biomimetic coating products, which is covalently bonded to the surface of a device and is designed to promote rapid healing. It was used in the treatment of diseased saphenous vein grafts, aneurysms and perforations. The company was headquartered in Menlo Park, CA